Advertisement
Extent of ablated tumor coverage is a significant prognostic factor
Why some teams work better than others
How medical jargon inhibits patient understanding
Tumor factors are more significant, says new study
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Study includes largest cohort to date
Multigene panel testing valuable regardless of age, cancer history
Increased invasive disease-free survival, disease-free survival and overall survival
Prescreening for clots also effective
Should lead to better treatment
High-risk and real-world patients responded
Advertisement
Advertisement